Skip to content

Neuro-ophthalmology and Autoimmune Encephalitis (NODE)

Study of Neuro-ophthalmology Disorders in Autoimmune Encephalitis (NODE)

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03872284
Acronym
NODE
Enrollment
2
Registered
2019-03-13
Start date
2020-01-22
Completion date
2020-02-26
Last updated
2025-01-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Autoimmune Encephalitis

Brief summary

Autoimmune encephalitis represents a group of rare and heterogeneous neurological disorders. Pathophysiological mechanisms in these diseases are still unknown. Recently, oculomotor and neurovisual disorders have been described. Cerebral areas and neuronal networks associated with these abnormalities are well described. The investigator proposes to study and describe such neuro-ophthalmological disorders in a prospective cohort of patients with a autoimmune encephalitis, to better understand the pathophysiological basis of this neurological condition.

Interventions

OTHERoculomotor movement recordings, neurovisual assessment

Each participant will have a neurovisual assessment and an oculomotor movement recording with an eye tracker (infra red cameras).

Sponsors

Hospices Civils de Lyon
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 70 Years
Healthy volunteers
No

Inclusion criteria

* Diagnosis of autoimmune encephalitis * With or without pathological antibody * Aged from 18 to 70 years old * Able to understand the aims and methods of this project * Non opposed to the participation of this study

Exclusion criteria

* Other neurological, psychiatric or systemic conditions, which could induce neuro-ophthalmological signs Cognitive impairment, which is not linked to autoimmune encephalitis * Ophthalmological condition, which could modify the interpretation of neuro-ophthalmological data Inability to remain seated * Pregnancy or breast feeding * Adults under guardianship

Design outcomes

Primary

MeasureTime frameDescription
Percentage of patients presenting a neuro-ophthalmological abnormality.Day 0A neuro-ophthalmological disorder is defined as an abnormality in the oculo-motor movement recording or/and the presence of a neurovisual impairment.
Percentage of patients presenting neuro-ophthalmological abnormality.At 6 months if an abnormality is foundA neuro-ophthalmological disorder is defined as an abnormality in the oculo-motor movement recording or/and the presence of a neurovisual impairment.

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026